In the news

News headlines are articles that reference ResMed's company, people, or business practices.

Advanced Search
  • October 15, 2018
    Health Europa

    Vice-president of medical affairs at ResMed, discusses the high burden of sleep apnoea in Europe and how best the health community can respond.

  • October 10, 2018
    MedCity News

    How ResMed and other companies use technology to provide a more holistic approach to patient's health, or even to get them past the mental barriers to improving their lifestyles.

  • September 11, 2018
    MedTech Talk

    Today, CEO Mick Farrell has ResMed beginning to take a very different path, migrating away from pure medical device sales and into selling software and other tech services to physicians.

  • August 8, 2018
    The Constant Investor (subscription)

    A 20-minute interview with ResMed President and COO Rob Douglas about the company's recent revenue growth, and how it plans to sustain it moving forward.

  • July 31, 2018
    Pharma Intelligence

    ResMed recognized for developing AirMini, "an innovative medical device or diagnostic that makes significant contributions to advancing patient treatment, and was launched between January 1, 2017 and May 31, 2018.”

  • July 30, 2018
    University of Washington

    A mobile technology conceived and researched at the University of Washington’s Paul G. Allen School of Computer Science & Engineering and UW Medicine designed to track breathing and body movements without requiring contact with the human body, has helped inspire the active sonar portion of the just-launched SleepScore mobile application, available worldwide to iOS and Android users.

  • July 12, 2018
    CNBC

    ResMed and Verily are investing an undisclosed amount in the as-yet-unnamed venture, and is focused on sleep apnea and other sleep breathing disorders. This is not the first time that Verily has partnered with a life sciences company for a joint venture: It is also working with Johnson & Johnson on an effort called Verb Surgical to develop a next-generation surgical robot.

  • June 15, 2018
    HME News

    ResMed and Xealth have launched a pilot project that allows primary care physicians at Providence St. Joseph Health to access data from CPAP devices right from their electronic medical record software.

  • Sleep Review logo
    June 3, 2018
    Sleep Review

    A new ResMed-funded retrospective study explores a potential factor of long-term adherence: mask resupply programs.

  • Mass Device logo
    May 21, 2018
    MassDevice

    ResMed today released data from two clinical analyses exploring combined home oxygen therapy and non-invasive ventilation therapy for patients with persistent hypercapnia following a life-threatening exacerbation of COPD, touting an increase in cost efficiency with the combined therapy.

  • April 27, 2018
    HME News

    ResMed reported 16% growth on a constant currency basis in the third quarter [of Fiscal Year 2018] for Europe, Asia and other markets, compared to 8% in the second quarter.

  • MD+DI logo
    April 24, 2018
    MD+DI

    One of medtech’s most connected health technology companies has just hired its first chief technology officer.

  • April 16, 2018
    Sleep Review

    Once a PAP user has a full-face mask that fits properly, Justus offers these tips for clinicians and patients on keeping the fit “just right": Magnets or a marker; regular cleaning; and scheduled resupply.

  • April 15, 2018
    San Diego Business Journal (subscription)

    In recent years, strong demand and a digital transformation spurred ResMed’s growth. The company posted $2.07 billion in 2017 revenue, up 37.1 percent from 2013, when Farrell took over as CEO. The company’s market cap went from $6 billion to nearly $14 billion in this span. Farrell said the market remains vastly underpenetrated. He’s pushing big data to break through.

  • April 3, 2018
    Medical Design & Outsourcing

    One company, ResMed (NYSE: RMD), has taken on the challenge of helping users become more compliant, the ecosystem more cost-effective and customers more loyal through a model of connected health. San Diego–based ResMed’s quest to improve patient compliance began over a decade ago, explained CEO Mick Farrell. “We started our first digital health experiments with UC San Diego in 2002 and learned a lot over a decade.”

  • February 21, 2018
    CommonWell Alliance

    Why did we at Brightree embrace FHIR for our connectivity with CommonWell and other portions of our interoperability solutions sets? We are writing today to help folks understand how we view FHIR fitting into the post-acute interoperability world and our interoperability commitment.

  • February 7, 2018
    News release

    The GEMCO-Brightree partnership simplifies the ordering process for DME/HME dealers by allowing them to place GEMCO orders directly from the Brightree Integrated ePurchasing platform. This streamlined process allows providers to reduce costs and increase revenue with no additional charge for integration.

  • January 19, 2018
    HomeCare

    “One of the greatest benefits of connected health is its ability to segment patient populations in the ways that will more efficiently help patients and their home care providers,” says Jeremy Malecha, VP of SaaS Strategy Development for ResMed. “Among sleep apnea patients, for instance, it’s crucial for HMEs to know how well their patients are adhering to PAP (positive airway pressure) therapy. When the right information is presented quickly and clearly, HMEs can more easily determine which patients need what types of support to improve health outcomes—and prioritize based on urgency and available resources.”

  • December 8, 2017
    Berg Insight

    Berg Insight estimates that the installed base of connected sleep therapy devices reached 3.4 million units at the end of 2016, which can be compared with 2.0 million units in 2015. The rapid increase is to a large extent due to ResMed’s push in the market. ResMed has established itself as the clear market leader in remote monitoring of sleep therapy patients with an estimated 2.0 million connected patients at the end of 2016.

  • December 6, 2017
    MD+DI

    ResMed has been named a 2017 “Medtech Company of the Year” finalist by MD+DI, a leading news resource in the medical device and diagnostic industry.

  • November 7, 2017
    mobiHealthNews

    Monitoring sleep disorders while traveling just became easier this week after the San Diego based company, ResMed announced that the AirMini, a miniature CPAP device, will now to be able to connect to the AirView, a remote patient monitoring platform.

  • October 2, 2017
    Seeking Alpha

    ResMed I thought was a great BUY in the $60 per share range, and a good buy at $73. It still is for investors after topping an all-time high price.

  • September 14, 2017
    San Diego Business Journal

    San Diego-based companies like ResMed and NuVasive Inc. argue the tax stifles research and development, job creation and innovation.

  • September 12, 2017
    HME News

    The use of CPAP telemonitoring with automated feedback messaging improved 90-day adherence in patients with obstructive sleep apnea, according to a ResMed-supported study published in American Journal of Respiratory and Clinical Care Medicine.

Show 5102550100 per page
Media contacts - Bottom Blue - All Interior Pages

Media contact

Jayme Rubenstein
(858) 836-6798

news@resmed.com

 

Receive ResMed news releases when they publish.

Subscribe

ResMed provides a non-transferable, non-exclusive license to the copyrighted images, drawings and materials subject to the following Terms of Use.

All countries & languages